Therefore, reversal of the immunosuppressive TME is a promising anti tumor therapeutic strategy, and several immune checkpoint inhibitors ICIs that target exhausted and regulatory T cells have been developed in recent years 8, 9 oral ivermectin Bromocriptine may be considered in patients with severe LV dysfunction